cmv Antibody
cmv Antibody
) CMV Control lentiviral particles (Bsd) |
|||
| CMV-Null-Bsd | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (Neo) |
|||
| CMV-Null-Neo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (Puro) |
|||
| CMV-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (GFP-Bsd) |
|||
| CMV-Null-GB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (GFP-Puro) |
|||
| CMV-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (RFP-Bsd) |
|||
| CMV-Null-RB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (RFP-Puro) |
|||
| CMV-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
 in PBS) CMV Control lentiviral particles (Bsd) in PBS |
|||
| CMV-Null-Bsd-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (Neo) in PBS |
|||
| CMV-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (GFP-Bsd) in PBS |
|||
| CMV-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (GFP-Puro) in PBS |
|||
| CMV-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (RFP-Bsd) in PBS |
|||
| CMV-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (RFP-Puro) in PBS |
|||
| CMV-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 CMV antibody |
|||
| 10R-C180a | Fitzgerald | 1 mg | EUR 447 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10C-CR1294M1 | Fitzgerald | 100 ug | EUR 358 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10C-CR2126M1 | Fitzgerald | 200 ug | EUR 624 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-1439 | Fitzgerald | 200 ug | EUR 692 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50C | Fitzgerald | 200 ug | EUR 692 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50D | Fitzgerald | 200 ug | EUR 692 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50F | Fitzgerald | 200 ug | EUR 692 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50G | Fitzgerald | 200 ug | EUR 692 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50L | Fitzgerald | 1 mg | EUR 138 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50M | Fitzgerald | 1 mg | EUR 133 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50N | Fitzgerald | 1 mg | EUR 133 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50P | Fitzgerald | 200 ug | EUR 732 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 10-C50R | Fitzgerald | 200 ug | EUR 241 |
|
Description: Mouse monoclonal CMV antibody |
|||
|
CMV antibody |
|||
| 20-CG70 | Fitzgerald | 1 mg | EUR 116 |
|
Description: Goat polyclonal CMV antibody |
|||
 CMV Antibody |
|||
| abx022961-1ml | Abbexa | 1 ml | EUR 732 |
|
|||
|
CMV Antibody |
|||
| abx021636-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
|
CMV Antibody |
|||
| abx021637-1mg | Abbexa | 1 mg | EUR 1372 |
|
|||
|
CMV Antibody |
|||
| abx021638-1mg | Abbexa | 1 mg | EUR 1205 |
|
|||
|
CMV Antibody |
|||
| abx021639-1mg | Abbexa | 1 mg | EUR 2332 |
|
|||
|
CMV Antibody |
|||
| abx021640-100ug | Abbexa | 100 ug | EUR 662 |
|
|||
|
CMV Antibody |
|||
| abx021641-1mg | Abbexa | 1 mg | EUR 1567 |
|
|||
|
CMV Antibody |
|||
| abx021642-100ug | Abbexa | 100 ug | EUR 592 |
|
|||
|
CMV Antibody |
|||
| abx021643-100ug | Abbexa | 100 ug | EUR 662 |
|
|||
 CMV gB antibody |
|||
| 10R-H106a | Fitzgerald | 100 ug | EUR 349 |
|
Description: Mouse monoclonal CMV gB antibody |
|||
 CMV ICP36 antibody |
|||
| 10-C50I | Fitzgerald | 100 ug | EUR 274 |
|
Description: Mouse monoclonal CMV ICP36 antibody |
|||
 CMV pp65 antibody |
|||
| 10-C50K | Fitzgerald | 200 ug | EUR 369 |
|
Description: Mouse monoclonal CMV pp65 antibody |
|||
) CMV antibody (biotin) |
|||
| 60C-CR2126GB | Fitzgerald | 1 ml | EUR 363 |
|
Description: Goat polyclonal CMV antibody (biotin) conjugated |
|||
) CMV antibody (FITC) |
|||
| 60-C69 | Fitzgerald | 1 ml | EUR 336 |
|
Description: Goat polyclonal CMV antibody (FITC) conjugated |
|||
) CMV antibody (HRP) |
|||
| 60-C70 | Fitzgerald | 1 ml | EUR 400 |
|
Description: Goat polyclonal CMV antibody (HRP) conjugated |
|||
 Anti-CMV antibody |
|||
| STJ180079 | St John's Laboratory | 0.1 ml | EUR 212 |
 CMV p28 UL99 antibody |
|||
| 10-C50J | Fitzgerald | 200 ug | EUR 273 |
|
Description: Mouse monoclonal CMV p28 UL99 antibody |
|||
 Antibody) CMV-p65(CMV100) Antibody |
|||
| BNUB0100-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against CMV-p65(CMV100), Concentration: 0.2mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNUB0100-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against CMV-p65(CMV100), Concentration: 0.2mg/mL |
|||
 Antibody) CMV-p65(CMV101) Antibody |
|||
| BNUB0101-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against CMV-p65(CMV101), Concentration: 0.2mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNUB0101-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against CMV-p65(CMV101), Concentration: 0.2mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNUM0100-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against CMV-p65(CMV100), 1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNUM0101-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against CMV-p65(CMV101), 1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC040100-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV100), CF405S conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC040100-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV100), CF405S conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC040101-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV101), CF405S conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC040101-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV101), CF405S conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC610100-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV100), CF660R conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC610100-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV100), CF660R conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC610101-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV101), CF660R conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC610101-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV101), CF660R conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC470100-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV100), CF647 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC470100-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV100), CF647 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC470101-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV101), CF647 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC470101-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV101), CF647 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC550100-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC550100-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC550101-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC550101-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC050100-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV100) Antibody |
|||
| BNC050100-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
|||
|
CMV-p65(CMV101) Antibody |
|||
| BNC050101-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CMV-p65(CMV101), CF405M conjugate, Concentration: 0.1mg/mL |
|||